Assembly Biosciences, Inc. Accumulated Other Comprehensive Income
Assembly Biosciences, Inc. (ASMB) had Accumulated Other Comprehensive Income of -$623.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-13
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$623.00K.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$368.00K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$41.00K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$90.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax | Accumulated Other Comprehensive Income (Loss), Net of Tax as first filed |
|---|---|---|
| 2026-06-30 | -$623.00K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | -$368.00K 10-Q · filed 2026-05-07 | |
| 2025-12-31 | -$41.00K 10-Q · filed 2026-08-13 | |
| 2025-09-30 | -$90.00K 10-Q · filed 2025-11-10 | |
| 2025-06-30 | -$279.00K 10-Q · filed 2025-08-06 | |
| 2025-03-31 | -$253.00K 10-Q · filed 2025-05-08 | |
| 2024-12-31 | -$211.00K 10-K · filed 2026-03-19 | |
| 2024-09-30 | -$156.00K 10-Q · filed 2024-11-07 | |
| 2024-06-30 | -$293.00K 10-Q · filed 2024-08-08 | |
| 2024-03-31 | -$239.00K 10-Q · filed 2024-05-08 | |
| 2023-12-31 | -$81.00K 10-K · filed 2025-03-20 | |
| 2023-09-30 | -$275.00K 10-Q · filed 2023-11-08 | |
| 2023-06-30 | -$325.00K 10-Q · filed 2023-08-09 | |
| 2023-03-31 | -$513.00K 10-Q · filed 2023-05-04 | |
| 2022-12-31 | -$803.00K 10-K · filed 2024-03-28 | |
| 2022-09-30 | -$999.00K 10-Q · filed 2022-11-08 | |
| 2022-06-30 | -$998.00K 10-Q · filed 2022-08-09 | |
| 2022-03-31 | -$908.00K 10-Q · filed 2022-05-12 | |
| 2021-12-31 | -$419.00K 10-K · filed 2023-03-22 | |
| 2021-09-30 | -$288.00K 10-Q · filed 2021-11-04 | |
| 2021-06-30 | -$273.00K 10-Q · filed 2021-08-05 | |
| 2021-03-31 | -$271.00K 10-Q · filed 2021-05-06 | |
| 2020-12-31 | -$270.00K 10-K · filed 2022-03-11 | |
| 2020-09-30 | -$158.00K 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $104.00K 10-Q · filed 2020-08-05 | |
| 2020-03-31 | -$86.00K 10-Q · filed 2020-05-08 | |
| 2019-12-31 | -$201.00K 10-K · filed 2021-02-25 | |
| 2019-09-30 | -$205.00K 10-Q · filed 2019-11-07 | |
| 2019-06-30 | -$187.00K 10-Q · filed 2019-08-05 | |
| 2019-03-31 | -$239.00K 10-Q · filed 2019-05-09 | |
| 2018-12-31 | -$347.00K 10-K · filed 2020-03-04 | |
| 2018-09-30 | -$354.90K 10-Q · filed 2018-11-08 | |
| 2018-06-30 | -$372.08K 10-Q · filed 2018-08-08 | |
| 2018-03-31 | -$459.35K 10-Q · filed 2018-05-07 | |
| 2017-12-31 | -$392.00K 10-K · filed 2019-02-28 | -$392.39K 10-K · filed 2018-03-08 |
| 2017-09-30 | -$388.39K 10-Q · filed 2017-11-01 | |
| 2017-06-30 | -$398.27K 10-Q · filed 2017-08-09 | |
| 2017-03-31 | -$524.68K 10-Q · filed 2017-05-08 | |
| 2016-12-31 | -$600.77K 10-K · filed 2018-03-08 | |
| 2016-09-30 | -$836.57K 10-Q · filed 2016-11-09 | |
| 2016-06-30 | -$839.36K 10-Q · filed 2016-08-09 | |
| 2016-03-31 | -$749.50K 10-Q · filed 2016-05-10 | |
| 2015-12-31 | -$821.59K 10-K · filed 2017-03-02 | |
| 2015-09-30 | -$387.88K 10-Q · filed 2015-11-09 | |
| 2015-06-30 | -$134.22K 10-Q · filed 2015-08-13 | |
| 2014-12-31 | $0.00 10-K · filed 2016-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |